Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Shares Outstanding (Weighted Average) (2016 - 2026)

Rockwell Medical filings provide 16 years of Shares Outstanding (Weighted Average) readings, the most recent being $36.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 15.83% to $36.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.0 million, a 15.83% increase, with the full-year FY2025 number at $36.0 million, up 15.83% from a year prior.
  • Shares Outstanding (Weighted Average) hit $36.0 million in Q4 2025 for Rockwell Medical, roughly flat from $36.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $36.0 million in Q3 2025 to a low of $8.5 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $20.0 million (2023), compared with a mean of $21.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 88.73% in 2021 and later skyrocketed 114.88% in 2023.
  • Rockwell Medical's Shares Outstanding (Weighted Average) stood at $8.5 million in 2021, then surged by 67.77% to $14.3 million in 2022, then soared by 63.05% to $23.3 million in 2023, then soared by 33.17% to $31.1 million in 2024, then rose by 15.83% to $36.0 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $36.0 million (Q4 2025), $36.0 million (Q3 2025), and $34.2 million (Q2 2025) per Business Quant data.